I agree that Sanofi Rare Blood Disorders and its agents (such as third-party business partners) can contact me by mail, email, fax and/or telephone, including calls and text messages, and send me information about rare blood disorders and relevant Sanofi products, promotions, services, and research studies, ask my opinion about such information and topics, including through market research and disease-related surveys, and share the information I provide with one another to perform these activities, and to de-identify it for use in performing research, education, business analytics, marketing studies, and other commercial purposes. I understand that text messaging rates may apply. Your information will not be sold to any third party but may be provided to regulatory authorities if required. You may have certain rights under applicable data privacy laws regarding your personal information, including the right to access your personal information held by Sanofi. For further information regarding these rights, please reference our Global Privacy Policy. You may opt out of continued receipt of such communications at any time by e-mailing RBDPatientSolutions@sanofi.com.
This site is intended for U.S. residents only.
© 2022 Genzyme Corporation. All rights reserved.
Sanofi is a registered trademark of Sanofi or an affiliate. All other trademarks are the property of their respective owners.
MAT-US-2107338 v2.0 05/2022 Last Updated: May 2022